Atorvastatin Related Products
Atorvastatin is a medication commonly used to lower cholesterol levels, specifically low-density lipoprotein (LDL) or "bad" cholesterol, and triglycerides in the blood. It's part of a class of drugs known as statins, which work by inhibiting an enzyme in the liver called HMG-CoA reductase.
Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Atorvastatin, pharmacopeial and non-pharmacopeial Atorvastatin impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Atorvastatin impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Atorvastatin-related products are thoroughly characterized. Atorvastatin products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.
Pharmaceutical Reference Standards
(3R,5R)-Atorvastatin Amide
VS CAT No | : VS-A037084 |
CAS No | : 2125501-02-0 |
Mol.F. | : C33H36FN3O4 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
(3R,5S)-Atorvastatin
VS CAT No | : VS-A037015 |
CAS No | : 651770-09-1 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1312366-79-2 (Ca salt) |
(3R,5S)-Atorvastatin Calcium salt
VS CAT No | : VS-A037072 |
CAS No | : 1312366-79-2 |
Mol.F. | : C33H35FN2O5 : 1/2(Ca) |
Mol.Wt. | : 558.7 : 1/2 (40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 651770-09-1 (free base) |
3-Des Hydroxy Atorvastatin
VS CAT No | : VS-A037148 |
CAS No | : 887196-26-1 |
Mol.F. | : C33H35FN2O4 |
Mol.Wt. | : 542.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin (3S,5R)-Isomer Methyl Ester
VS CAT No | : VS-A037016 |
CAS No | : NA |
Mol.F. | : C34H37FN2O5 |
Mol.Wt. | : 572.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin 2-Fluoro Analog
VS CAT No | : VS-A037019 |
CAS No | : 2243639-97-4 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 2243639-98-5 (Ca salt) |
Atorvastatin 2-Hydroxy Analog
VS CAT No | : VS-A037116 |
CAS No | : 214217-86-4 |
Mol.F. | : C33H35FN2O6 |
Mol.Wt. | : 574.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 265989-46-6 (Ca salt) ; 163217-75-2 (Na salt) |
Atorvastatin 2-Hydroxy Analog Calcium salt
VS CAT No | : VS-A037021 |
CAS No | : 265989-46-6 |
Mol.F. | : C33H34FN2O6 : 1/2(Ca) |
Mol.Wt. | : 574.7 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 214217-86-4 (free base) ; 163217-75-2 (Na salt) |
Atorvastatin 2-Hydroxy Analog Sodium salt
VS CAT No | : VS-A037023 |
CAS No | : 163217-75-2 |
Mol.F. | : C33H34FN2O6 : Na |
Mol.Wt. | : 573.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 265989-46-6 (Ca salt) |
Atorvastatin 2-Hydroxy Lactone
VS CAT No | : VS-A037022 |
CAS No | : 163217-74-1 |
Mol.F. | : C33H33FN205 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin 2,3-Anhydro Lactone
VS CAT No | : VS-A037018 |
CAS No | : 442851-50-5 |
Mol.F. | : C33H31FN2O3 |
Mol.Wt. | : 522.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin 2,3,4,5-Dianhydro Acid
VS CAT No | : VS-A037017 |
CAS No | : 2588261-49-6 |
Mol.F. | : C33H31FN2O3 |
Mol.Wt. | : 522.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 2588261-50-9 (Ca salt) |
Atorvastatin 2,3,4,5-Dianhydro Acid Calcium salt
VS CAT No | : VS-A037090 |
CAS No | : 2588261-50-9 |
Mol.F. | : C33H31FN2O3 : 1/2(Ca) |
Mol.Wt. | : 522.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 2588261-49-6 |
Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Ethyl Ester
VS CAT No | : VS-A037024 |
CAS No | : 1624328-52-4 |
Mol.F. | : C35H37FN2O4 |
Mol.Wt. | : 568.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin 3-Oxo Methyl Ester
VS CAT No | : VS-A037028 |
CAS No | : 110862-47-0 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 570.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin 3-Oxopropyl Impurity
VS CAT No | : VS-A037029 |
CAS No | : 110862-46-9 |
Mol.F. | : C29H27FN2O2 |
Mol.Wt. | : 454.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin 4-Hydroxy Calcium
VS CAT No | : VS-A037030 |
CAS No | : 1263176-34-6 |
Mol.F. | : C33H34FN2O6 : 1/2(Ca) |
Mol.Wt. | : 573.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Atorvastatin 4-Hydroxy Disodium Salt
VS CAT No | : VS-A037031 |
CAS No | : 214217-88-6 |
Mol.F. | : C33H33FN2NaO6 : Na |
Mol.Wt. | : 595.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Atorvastatin 4-Hydroxy Lactone
VS CAT No | : VS-A037032 |
CAS No | : 163217-70-7 |
Mol.F. | : C33H33FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin 5-O-Methyl Sodium
VS CAT No | : VS-A037033 |
CAS No | : NA |
Mol.F. | : C34H36FN2O5 : Na |
Mol.Wt. | : 571.7 : 23.0 |
Inv. Status | : Custom Synthesis |
Atorvastatin 5-Oxo Acid
VS CAT No | : VS-A037034 |
CAS No | : 1391052-82-6 |
Mol.F. | : C33H33FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin 5-Oxo Acid (Sodium salt)
VS CAT No | : VS-A037146 |
CAS No | : NA |
Mol.F. | : C33H33FN2O5 : Na |
Mol.Wt. | : 556.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1391052-82-6 (free base) |
Atorvastatin Acetonide Methyl Ester
VS CAT No | : VS-A037036 |
CAS No | : 1353049-81-6 |
Mol.F. | : C37H41FN2O5 |
Mol.Wt. | : 612.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acetonide t-Butyl Ester (3S,5S)-Isomer
VS CAT No | : VS-A037037 |
CAS No | : 472967-95-6 |
Mol.F. | : C40H47FN2O5 |
Mol.Wt. | : 654.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acetonide t-Butyl Ester (4S, 6R)-Isomer
VS CAT No | : VS-A037038 |
CAS No | : 1105067-90-0 |
Mol.F. | : C40H47FN2O5 |
Mol.Wt. | : 654.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acetonide t-Butyl Ester Side Chain (4R,6R)-Isomer
VS CAT No | : VS-A037039 |
CAS No | : 125971-94-0 |
Mol.F. | : C14H23NO4 |
Mol.Wt. | : 269.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acetonide t-Butyl Ester Side Chain (4S,6R)-Isomer
VS CAT No | : VS-A037041 |
CAS No | : 186508-95-2 |
Mol.F. | : C14H23NO4 |
Mol.Wt. | : 269.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acetonide t-Butyl Ester Side Chain (4S,6S)-Isomer
VS CAT No | : VS-A037042 |
CAS No | : 196085-85-5 |
Mol.F. | : C14H23NO4 |
Mol.Wt. | : 269.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acid
VS CAT No | : VS-A037043 |
CAS No | : 134523-00-5 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 134523-01-6 (Na salt) ; 134523-03-8 (Ca salt) |
Atorvastatin Acid Isopropyl Ester
VS CAT No | : VS-A037045 |
CAS No | : 1035205-25-4 |
Mol.F. | : C36H41FN2O5 |
Mol.Wt. | : 600.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Acid Sodium salt
VS CAT No | : VS-A037025 |
CAS No | : 134523-01-6 |
Mol.F. | : C33H34FN2O5 : Na |
Mol.Wt. | : 557.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 134523-00-5 (free base) ; 134523-03-8 (Ca salt) |
Atorvastatin Acyl-beta-D-Glucuronide
VS CAT No | : VS-A037048 |
CAS No | : 463962-58-5 |
Mol.F. | : C39H43FN2O11 |
Mol.Wt. | : 734.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Amide
VS CAT No | : VS-A037097 |
CAS No | : 2733752-57-1 |
Mol.F. | : C40H52FN3O8 |
Mol.Wt. | : 721.9 |
Inv. Status | : Custom Synthesis |
Atorvastatin Calcium
VS CAT No | : VS-A037082 |
CAS No | : 134523-03-8 |
Mol.F. | : C33H34FN2O5 : 1/2(Ca) |
Mol.Wt. | : 557.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 344423-98-9 (Ca salt Trihydrate) |
Atorvastatin Calcium Lactone Diepoxide
VS CAT No | : VS-A037095 |
CAS No | : NA |
Mol.F. | : C33H32FN2O6 : Ca |
Mol.Wt. | : 571.6 : 40.1 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1046118-40-4 (free base) |
Atorvastatin Calcium Propylene Glycol Solvate
VS CAT No | : VS-A037124 |
CAS No | : 1040350-07-9 |
Mol.F. | : C33H35FN2O5 : 1/2(Ca) : C3H8O2 |
Mol.Wt. | : 558.7 : 1/2(40.1) : 76.1 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 134523-00-5 (free base) ; 134523-01-6 (Na salt) ; 134523-03-8 (Ca salt) |
Atorvastatin Calcium Trihydrate
VS CAT No | : VS-A037001 |
CAS No | : 344423-98-9 |
Mol.F. | : C33H34FN2O5 : 1/2(Ca) : 3/2H2O |
Mol.Wt. | : 557.6 : 1/2(40.1) : 3/2(18.0) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 134523-00-5 (free base) ; 134523-01-6 (Na salt) ; 134523-03-8 (Ca salt) |
Atorvastatin Diamino Impurity
VS CAT No | : VS-A037078 |
CAS No | : 1116118-82-1 |
Mol.F. | : C50H64FN3O8 |
Mol.Wt. | : 854.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diamino Impurity
VS CAT No | : VS-A037140 |
CAS No | : 2299304-89-3 |
Mol.F. | : C24H44N2O7 |
Mol.Wt. | : 472.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diepoxide
VS CAT No | : VS-A037117 |
CAS No | : 887470-43-1 |
Mol.F. | : C33H35FN2O7 |
Mol.Wt. | : 590.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1807481-01-1 (Ca salt) |
Atorvastatin Diepoxide Calcium Salt
VS CAT No | : VS-A037050 |
CAS No | : 1807481-01-1 |
Mol.F. | : C33H34FN2O7 : 1/2(Ca) |
Mol.Wt. | : 589.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887470-43-1 (free base) |
Atorvastatin Difluoro Impurity
VS CAT No | : VS-A037127 |
CAS No | : 693793-82-7 |
Mol.F. | : C26H23F2NO3 |
Mol.Wt. | : 435.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diketo Amide 2-Fluoro Analog
VS CAT No | : VS-A037052 |
CAS No | : 1797905-42-0 |
Mol.F. | : C26H24FNO3 |
Mol.Wt. | : 417.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diketo Amide Impurity
VS CAT No | : VS-A037053 |
CAS No | : 125971-96-2 |
Mol.F. | : C26H24FNO3 |
Mol.Wt. | : 417.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diketoene Impurity
VS CAT No | : VS-A037054 |
CAS No | : 1331869-19-2 |
Mol.F. | : C26H22FNO3 |
Mol.Wt. | : 415.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Diol Methyl Ester
VS CAT No | : VS-A037128 |
CAS No | : NA |
Mol.F. | : C34H38FN3O5 |
Mol.Wt. | : 587.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity A (Sodium salt)
VS CAT No | : VS-A037002 |
CAS No | : 1516864-05-3 |
Mol.F. | : C33H35N2O5 : Na |
Mol.Wt. | : 539.7 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 433289-84-0 (free base) ; 433289-83-9 (Calcium salt) |
Atorvastatin EP Impurity A Calcium salt
VS CAT No | : VS-A037109 |
CAS No | : 433289-83-9 |
Mol.F. | : C33H35N2O5 : 1/2(Ca) |
Mol.Wt. | : 539.7 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 433289-84-0 (free base) ; 1516864-05-3 (Na salt) |
Atorvastatin EP Impurity B
VS CAT No | : VS-A037003 |
CAS No | : 842103-12-2 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 840528-19-0 (Ca salt) |
Atorvastatin EP Impurity B Calcium salt
VS CAT No | : VS-A037110 |
CAS No | : 840528-19-0 |
Mol.F. | : C33H34FN2O5 : 1/2(Ca) |
Mol.Wt. | : 557.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 842103-12-2 (free base) |
Atorvastatin EP Impurity C (Calcium Salt)
VS CAT No | : VS-A037004 |
CAS No | : 693793-53-2 |
Mol.F. | : C33H34F2N2O5 : 1/2(Ca) |
Mol.Wt. | : 576.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 693794-20-6 (free base) ; 1807481-00-0 (Na salt) |
Atorvastatin EP Impurity C Sodium salt
VS CAT No | : VS-A037086 |
CAS No | : 1807481-00-0 |
Mol.F. | : C33H34F2N2O5 : Na |
Mol.Wt. | : 576.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 693793-53-2 (Ca salt) ; 693794-20-6 (free base) |
Atorvastatin EP Impurity D
VS CAT No | : VS-A037071 |
CAS No | : NA |
Mol.F. | : C26H22FNO4 : C26H24FNO5 |
Mol.Wt. | : 431.5 : 449.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity D (D1)
VS CAT No | : VS-A037005 |
CAS No | : 148146-51-4 |
Mol.F. | : C26H22FNO4 |
Mol.Wt. | : 431.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity D (D2)
VS CAT No | : VS-A037055 |
CAS No | : 873950-19-7 |
Mol.F. | : C26H24FNO5 |
Mol.Wt. | : 449.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity E
VS CAT No | : VS-A037093 |
CAS No | : 501121-34-2 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.2 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1428118-38-0 (Na salt) ; 1105067-88-6 (Ca salt) |
Atorvastatin EP Impurity E (Na salt)
VS CAT No | : VS-A037006 |
CAS No | : 1428118-38-0 |
Mol.F. | : C33H34FN2O5 : Na |
Mol.Wt. | : 557.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 501121-34-2 (free base) ; 1105067-88-6 (Ca salt) |
Atorvastatin EP Impurity E Calcium salt
VS CAT No | : VS-A037066 |
CAS No | : 1105067-88-6 |
Mol.F. | : C33H34FN2O5 : 1/2(Ca) |
Mol.Wt. | : 557.6 : 1/2 (40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1428118-38-0 (Na salt) ; 501121-34-2 (free base) |
Atorvastatin EP Impurity F
VS CAT No | : VS-A037007 |
CAS No | : 887196-24-9 |
Mol.F. | : C40H48FN3O8 |
Mol.Wt. | : 717.8 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1371615-56-3 (Na salt) ; 2093520-34-2 (K salt) ; 1105067-87-5 (Ca salt) |
Atorvastatin EP Impurity F (Calcium Salt)
VS CAT No | : VS-A037049 |
CAS No | : 1105067-87-5 |
Mol.F. | : C40H48FN3O8 : 1/2(Ca) |
Mol.Wt. | : 717.8 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1371615-56-3 (Na salt) ; 2093520-34-2 (K salt) ; 887196-24-9 (free base) |
Atorvastatin EP Impurity F Sodium sal
VS CAT No | : VS-A037112 |
CAS No | : 1371615-56-3 |
Mol.F. | : C40H47FN3O8 : Na |
Mol.Wt. | : 716.8 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887196-24-9 (free base) ; 2093520-34-2 (K salt) ; 1105067-87-5 (Ca salt) |
Atorvastatin EP Impurity G
VS CAT No | : VS-A037073 |
CAS No | : 887324-53-0 |
Mol.F. | : C34H37FN2O5 |
Mol.Wt. | : 572.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887196-29-4 (Ca salt) |
Atorvastatin EP Impurity G (Calcium Salt)
VS CAT No | : VS-A037008 |
CAS No | : 887196-29-4 |
Mol.F. | : C34H36FN2O5 : 1/2(Ca) |
Mol.Wt. | : 571.7 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887324-53-0 (free base) |
Atorvastatin EP Impurity H
VS CAT No | : VS-A037009 |
CAS No | : 125995-03-1 |
Mol.F. | : C33H33FN2O4 |
Mol.Wt. | : 540.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity I
VS CAT No | : VS-A037010 |
CAS No | : 125971-95-1 |
Mol.F. | : C40H47FN2O5 |
Mol.Wt. | : 654.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity J
VS CAT No | : VS-A037012 |
CAS No | : 1105067-93-3 |
Mol.F. | : C33H33FN2O4 |
Mol.Wt. | : 540.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity J (Calcium salt)
VS CAT No | : VS-A037104 |
CAS No | : NA |
Mol.F. | : C33H32FN2O4 : 1/2(Ca) |
Mol.Wt. | : 539.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1105067-93-3 (free base) |
Atorvastatin EP Impurity K
VS CAT No | : VS-A037046 |
CAS No | : 345891-62-5 |
Mol.F. | : C34H37FN2O5 |
Mol.Wt. | : 572.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity M
VS CAT No | : VS-A037044 |
CAS No | : 1146977-93-6 |
Mol.F. | : C35H39FN2O5 |
Mol.Wt. | : 586.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity Mixture (E & H)
VS CAT No | : VS-A037149 |
CAS No | : NA |
Mol.F. | : C33H35FN2O5 : C33H33FN2O4 |
Mol.Wt. | : 558.7 : 540.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity N
VS CAT No | : VS-A037047 |
CAS No | : 134395-00-9 |
Mol.F. | : C37H43FN2O5 |
Mol.Wt. | : 614.9 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity O
VS CAT No | : VS-A037107 |
CAS No | : 887196-30-7 |
Mol.F. | : C33H33FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin EP Impurity O Sodium salt
VS CAT No | : VS-A037027 |
CAS No | : NA |
Mol.F. | : C33H32FN2O5 : Na |
Mol.Wt. | : 555.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887196-30-7 (free base) |
Atorvastatin EP Impurity P
VS CAT No | : VS-A037035 |
CAS No | : 581772-29-4 |
Mol.F. | : C36H39FN2O5 |
Mol.Wt. | : 598.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 929540-41-0 (Ca salt) ; 862260-38-6 (Na salt) |
Atorvastatin EP Impurity P (Sodium salt)
VS CAT No | : VS-A037081 |
CAS No | : 862260-38-6 |
Mol.F. | : C36H39FN2O5 : Na |
Mol.Wt. | : 598.7 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 581772-29-4 (free base) ; 929540-41-0 (Ca salt) |
Atorvastatin EP Impurity Q
VS CAT No | : VS-A037074 |
CAS No | : 906552-18-9 |
Mol.F. | : C33H35FN2O6 |
Mol.Wt. | : 574.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1046118-41-5 (Ca salt) |
Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP)
VS CAT No | : VS-A037057 |
CAS No | : 1316291-19-6 |
Mol.F. | : C33H34FN2O7 : Na |
Mol.Wt. | : 589.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 873950-17-5 (free base) |
Atorvastatin Epoxy Pyrrolooxazin Tricyclic Analog
VS CAT No | : VS-A037013 |
CAS No | : NA |
Mol.F. | : C33H33FN2O6 |
Mol.Wt. | : 572.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 10
VS CAT No | : VS-A037051 |
CAS No | : 2588261-36-1 |
Mol.F. | : C37H44N2O5 |
Mol.Wt. | : 596.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 11
VS CAT No | : VS-A037067 |
CAS No | : 616201-27-5 |
Mol.F. | : C38H43FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 13
VS CAT No | : VS-A037075 |
CAS No | : 62148-67-8 |
Mol.F. | : C14H10ClFO |
Mol.Wt. | : 248.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 14
VS CAT No | : VS-A037076 |
CAS No | : 1403667-07-1 |
Mol.F. | : C14H9Cl2FO |
Mol.Wt. | : 283.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 15
VS CAT No | : VS-A037079 |
CAS No | : 444577-70-2 |
Mol.F. | : C26H25NO3 |
Mol.Wt. | : 399.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 16
VS CAT No | : VS-A037080 |
CAS No | : 363599-73-9 |
Mol.F. | : C36H39FN2O5 |
Mol.Wt. | : 598.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1402828-92-5 (Ca salt) |
Atorvastatin Impurity 17
VS CAT No | : VS-A037083 |
CAS No | : 666714-64-3 |
Mol.F. | : C26H23FN2O |
Mol.Wt. | : 398.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 18
VS CAT No | : VS-A037085 |
CAS No | : 141942-85-0 |
Mol.F. | : C7H11NO3 |
Mol.Wt. | : 157.2 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 21
VS CAT No | : VS-A037092 |
CAS No | : NA |
Mol.F. | : C37H43N3O6 |
Mol.Wt. | : 625.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 22
VS CAT No | : VS-A037096 |
CAS No | : 265989-44-4 |
Mol.F. | : C33H35FN2O6 : 1/2(Ca) |
Mol.Wt. | : 574.6 : 1/2 (40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 214217-88-6 (free base) |
Atorvastatin Impurity 23
VS CAT No | : VS-A037098 |
CAS No | : 366-68-7 |
Mol.F. | : C14H10F2O |
Mol.Wt. | : 232.2 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 24
VS CAT No | : VS-A037099 |
CAS No | : 77294-82-7 |
Mol.F. | : C14H11FO |
Mol.Wt. | : 214.2 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 25
VS CAT No | : VS-A037100 |
CAS No | : NA |
Mol.F. | : C26H23ClFNO3 |
Mol.Wt. | : 451.9 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 26
VS CAT No | : VS-A037101 |
CAS No | : 912998-82-4 |
Mol.F. | : C21H21FO4 |
Mol.Wt. | : 356.4 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 27
VS CAT No | : VS-A037102 |
CAS No | : NA |
Mol.F. | : C26H25NO3 |
Mol.Wt. | : 399.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 28
VS CAT No | : VS-A037103 |
CAS No | : 2514955-94-1 |
Mol.F. | : C14H9Br2FO |
Mol.Wt. | : 372.0 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 29
VS CAT No | : VS-A037106 |
CAS No | : 125971-93-9 |
Mol.F. | : C11H19NO4 |
Mol.Wt. | : 229.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 30
VS CAT No | : VS-A037122 |
CAS No | : 77294-83-8 |
Mol.F. | : C14H10ClFO |
Mol.Wt. | : 248.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 31
VS CAT No | : VS-A037123 |
CAS No | : 125988-01-4 |
Mol.F. | : C11H17NO4 |
Mol.Wt. | : 227.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 32
VS CAT No | : VS-A037125 |
CAS No | : 2591410-04-5 |
Mol.F. | : C33H33FN2O6 |
Mol.Wt. | : 572.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 33
VS CAT No | : VS-A037126 |
CAS No | : 40281-50-3 |
Mol.F. | : C14H11FO |
Mol.Wt. | : 214.2 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 34
VS CAT No | : VS-A037130 |
CAS No | : 1817798-20-1 |
Mol.F. | : C26H24FNO3 |
Mol.Wt. | : 417.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 35
VS CAT No | : VS-A037131 |
CAS No | : NA |
Mol.F. | : C27H29FNO6 : 1/2(Ca) |
Mol.Wt. | : 482.5 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 36
VS CAT No | : VS-A037132 |
CAS No | : 347-84-2 |
Mol.F. | : C14H11FO |
Mol.Wt. | : 214.2 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 37
VS CAT No | : VS-A037133 |
CAS No | : 88675-31-4 |
Mol.F. | : C14H10BrFO |
Mol.Wt. | : 293.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 38
VS CAT No | : VS-A037134 |
CAS No | : 124401-38-3 |
Mol.F. | : C12H15NO2 |
Mol.Wt. | : 205.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 39
VS CAT No | : VS-A037136 |
CAS No | : NA |
Mol.F. | : C11H21NO4 |
Mol.Wt. | : 231.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 40
VS CAT No | : VS-A037137 |
CAS No | : 1198087-00-1 |
Mol.F. | : C26H24FNO3 |
Mol.Wt. | : 417.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 41
VS CAT No | : VS-A037138 |
CAS No | : 125971-57-5 |
Mol.F. | : C19H19NO2 |
Mol.Wt. | : 293.4 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 42
VS CAT No | : VS-A037139 |
CAS No | : 54016-70-5 |
Mol.F. | : C8H14NOS : Br |
Mol.Wt. | : 172.3 : 79.9 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 45892-42-0 (free base) |
Atorvastatin Impurity 43
VS CAT No | : VS-A037142 |
CAS No | : NA |
Mol.F. | : C60H81FN4O11 |
Mol.Wt. | : 1053.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 44
VS CAT No | : VS-A037143 |
CAS No | : NA |
Mol.F. | : C47H60FN4O11 : Ca |
Mol.Wt. | : 876.0 : 40.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 45
VS CAT No | : VS-A037144 |
CAS No | : NA |
Mol.F. | : C33H31FN2O3 |
Mol.Wt. | : 522.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 46
VS CAT No | : VS-A037145 |
CAS No | : 31315-51-2 |
Mol.F. | : C14H10Cl2O |
Mol.Wt. | : 265.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 47
VS CAT No | : VS-A037150 |
CAS No | : 2409556-65-4 |
Mol.F. | : C44H56FN3O8 |
Mol.Wt. | : 773.9 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 48
VS CAT No | : VS-A037151 |
CAS No | : 125995-13-3 |
Mol.F. | : C14H27NO4 |
Mol.Wt. | : 273.4 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 931114-37-3 (HCl salt) |
Atorvastatin Impurity 49
VS CAT No | : VS-A037154 |
CAS No | : 1428118-12-0 |
Mol.F. | : C37H43FN2O5 |
Mol.Wt. | : 614.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 50
VS CAT No | : VS-A037155 |
CAS No | : 2588261-40-7 |
Mol.F. | : C37H42F2N2O5 |
Mol.Wt. | : 632.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 51
VS CAT No | : VS-A037158 |
CAS No | : 947262-20-6 |
Mol.F. | : C37H41FN2O5 |
Mol.Wt. | : 612.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 52
VS CAT No | : VS-A037159 |
CAS No | : NA |
Mol.F. | : C35H39FN2O5 |
Mol.Wt. | : 586.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 53
VS CAT No | : VS-A037160 |
CAS No | : 186508-94-1 |
Mol.F. | : C11H19NO4 |
Mol.Wt. | : 229.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 54
VS CAT No | : VS-A037161 |
CAS No | : 2088732-00-5 |
Mol.F. | : C11H19NO4 |
Mol.Wt. | : 229.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 55
VS CAT No | : VS-A037162 |
CAS No | : 1105067-89-7 |
Mol.F. | : C14H27NO4 |
Mol.Wt. | : 273.4 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 56
VS CAT No | : VS-A037163 |
CAS No | : 1371615-55-2 |
Mol.F. | : C47H60FN3O8 |
Mol.Wt. | : 814.0 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 57
VS CAT No | : VS-A037164 |
CAS No | : 124401-38-3 |
Mol.F. | : C12H15NO2 |
Mol.Wt. | : 205.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Impurity 58
VS CAT No | : VS-A037165 |
CAS No | : 95537-36-3 |
Mol.F. | : C6H11BrO3 |
Mol.Wt. | : 211.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Lactone 3-O-Methyl Ether
VS CAT No | : VS-A037058 |
CAS No | : NA |
Mol.F. | : C34H35FN2O4 |
Mol.Wt. | : 554.7 |
Inv. Status | : Custom Synthesis |
Atorvastatin Lactone Dimer
VS CAT No | : VS-A037059 |
CAS No | : NA |
Mol.F. | : C66H66F2N4O8 |
Mol.Wt. | : 1081.3 |
Inv. Status | : Custom Synthesis |
Atorvastatin Oxirane Impurity
VS CAT No | : VS-A037060 |
CAS No | : 1246818-88-1 |
Mol.F. | : C26H24FNO3 |
Mol.Wt. | : 417.5 |
Inv. Status | : Custom Synthesis |
Atorvastatin Phenyl Amino Impurity
VS CAT No | : VS-A037069 |
CAS No | : NA |
Mol.F. | : C39H40FN3O4 |
Mol.Wt. | : 633.8 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidine Phenanthrene Calcium
VS CAT No | : VS-A037094 |
CAS No | : NA |
Mol.F. | : C33H33N2O6 : Ca |
Mol.Wt. | : 553.6 : 40.1 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidone Analog Sodium salt (USP)
VS CAT No | : VS-A037014 |
CAS No | : 148217-40-7 |
Mol.F. | : C33H34FN2O6 : Na |
Mol.Wt. | : 573.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 691844-60-7 (free base) |
Atorvastatin Pyrrolidone Lactone (USP)
VS CAT No | : VS-A037061 |
CAS No | : 906552-19-0 |
Mol.F. | : C33H33FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidone Methyl Ester
VS CAT No | : VS-A037062 |
CAS No | : 1795790-02-1 |
Mol.F. | : C34H37FN2O6 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidone Phenanthrene
VS CAT No | : VS-A037118 |
CAS No | : 148217-41-8 |
Mol.F. | : C33H32FN2O6 : Na |
Mol.Wt. | : 571.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 745763-42-2 (free base) ; 148127-12-2 (Calcium salt) |
Atorvastatin Pyrrolidone Phenanthrene Calcium salt
VS CAT No | : VS-A037063 |
CAS No | : 148127-12-2 |
Mol.F. | : C33H32FN2O6 : 1/2(Ca) |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 745763-42-2 (free base) |
Atorvastatin Pyrrolidone Phenanthrene Lactone
VS CAT No | : VS-A037064 |
CAS No | : 1795791-15-9 |
Mol.F. | : C33H31FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidone Phenanthrene Methyl Ester
VS CAT No | : VS-A037065 |
CAS No | : 906552-20-3 |
Mol.F. | : C34H35FN2O6 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Atorvastatin Pyrrolidone Phenanthrene Sodium salt (R,R)
VS CAT No | : VS-A037068 |
CAS No | : 1428125-03-4 |
Mol.F. | : C33H32FN2O6 : Na |
Mol.Wt. | : 571.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1046533-62-3 (free base) |
Atorvastatin Triamino Impurity
VS CAT No | : VS-A037141 |
CAS No | : NA |
Mol.F. | : C34H61N3O10 |
Mol.Wt. | : 671.9 |
Inv. Status | : Custom Synthesis |
Atorvastatin USP Related Compound B
VS CAT No | : VS-A037114 |
CAS No | : 887324-52-9 |
Mol.F. | : C33H35FN2O5 |
Mol.Wt. | : 558.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887196-25-0 (Ca salt) |
Atorvastatin USP Related Compound B Sodium salt
VS CAT No | : VS-A037070 |
CAS No | : NA |
Mol.F. | : C33H35FN2O5 : Na |
Mol.Wt. | : 558.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887324-52-9 (free base) ; 887196-25-0 (Calcium salt) |
Atorvastatin USP Related Compound B (Calcium)
VS CAT No | : VS-A037011 |
CAS No | : 887196-25-0 |
Mol.F. | : C33H34FN2O5 : 1/2(ca) |
Mol.Wt. | : 557.6 : 1/2(40.1) |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 887324-52-9 (free base) |
Defluoro Atorvastatin Acetonide tert-Butyl Ester
VS CAT No | : VS-A037077 |
CAS No | : 1105067-91-1 |
Mol.F. | : C40H48N2O5 |
Mol.Wt. | : 636.8 |
Inv. Status | : Custom Synthesis |
Ortho-Hydroxy Atorvastatin Glucuronide
VS CAT No | : VS-A037153 |
CAS No | : NA |
Mol.F. | : C39H45FN2O12 |
Mol.Wt. | : 752.8 |
Inv. Status | : Custom Synthesis |
Para-Hdroxy Atorvastatin Glucuronide
VS CAT No | : VS-A037152 |
CAS No | : NA |
Mol.F. | : C39H45FN2O12 |
Mol.Wt. | : 752.8 |
Inv. Status | : Custom Synthesis |
Phenanthrene Atorvastatin
VS CAT No | : VS-A037091 |
CAS No | : 1046533-62-3 |
Mol.F. | : C33H33FN2O6 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Pyrrolidone Atorvastatin
VS CAT No | : VS-A037088 |
CAS No | : 496060-54-9 |
Mol.F. | : C33H35FN2O6 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
rac-3-Oxo Atorvastatin
VS CAT No | : VS-A037156 |
CAS No | : 1391194-36-7 |
Mol.F. | : C33H33FN2O5 |
Mol.Wt. | : 556.6 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1391052-00-8 (sodium salt) |
rac-3-Oxo Atorvastatin Calcium Salt
VS CAT No | : VS-A037105 |
CAS No | : NA |
Mol.F. | : C33H32FN2O5 : 1/2(Ca) |
Mol.Wt. | : 555.6 : 40.1 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1391194-36-7 (free base) ; 1391052-00-8 (Sodium salt) |
rac-3-Oxo Atorvastatin Sodium Salt
VS CAT No | : VS-A037157 |
CAS No | : 1391052-00-8 |
Mol.F. | : C33H32FN2O5 : Na |
Mol.Wt. | : 555.6 : 23.0 |
Inv. Status | : Custom Synthesis |
Stable Isotopes And Metabolites
2-Hydroxy Atorvastatin D5
VS CAT No | : VS-A037D06 |
CAS No | : 777841-55-1 |
Mol.F. | : C33H30D5FN2O6 |
Mol.Wt. | : 579.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 1276537-19-9 (Na salt) ; 265989-47-7 (Calcium salt) |
2-Hydroxy Atorvastatin Lactone-d5
VS CAT No | : VS-A037D04 |
CAS No | : 265989-50-2 |
Mol.F. | : C33H28D5FN2O5 |
Mol.Wt. | : 561.7 |
Inv. Status | : Custom Synthesis |
4-Hydroxy Atorvastatin D5
VS CAT No | : VS-A037D03 |
CAS No | : 767274-94-2 |
Mol.F. | : C33H29D5FN2O6 : Na |
Mol.Wt. | : 578.7 : 23.0 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 265989-45-5 (calcium salt) |
Atorvastatin D5
VS CAT No | : VS-A037D01 |
CAS No | : 749193-45-1 |
Mol.F. | : C33H29D5FN2O5 |
Mol.Wt. | : 562.7 |
Inv. Status | : Custom Synthesis |
Rel. CAS No | : 222412-87-5 (sodium salt) |
Possible Nitroso Standards
Atorvastatin Nitroso Impurity 1
VS CAT No | : VS-A037135 |
CAS No | : NA |
Mol.F. | : C26H22FN3O2 |
Mol.Wt. | : 427.5 |
Inv. Status | : Custom Synthesis |
N-Nitroso Atorvastatin Calcium
VS CAT No | : VS-A037129 |
CAS No | : NA |
Mol.F. | : C33H33FN3O6 : Ca |
Mol.Wt. | : 586.6 : 40.1 |
Inv. Status | : Custom Synthesis |